| p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. RS Alpan, AB Pardee Cell Growth & Differentiation: the Molecular Biology Journal of the American …, 1996 | 105 | 1996 |
| Bioequivalence study of clopidogrel bisulfate film-coated tablets A Lainesse, Y Ozalp, H Wong, RS Alpan Arzneimittelforschung 54 (09), 600-604, 2004 | 59 | 2004 |
| Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line RS Alpan, M Zhang, AB Pardee Cancer research 56 (19), 4358-4361, 1996 | 49 | 1996 |
| Bio equivalence study of atorvastatin tablets R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 573-577, 2004 | 45 | 2004 |
| Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population M Özer, Y Demirci, C Hızel, S Sarıkaya, İ Karaltı, Ç Kaspar, S Alpan, ... Basic & clinical pharmacology & toxicology 112 (3), 209-214, 2013 | 44 | 2013 |
| Inosine-containing primers for mRNA differential display M Rohrwild, RS Alpan, P Liang, AB Pardee Trends in Genetics 11 (8), 300-300, 1995 | 27 | 1995 |
| Combination of losartan and hydrochlorothiazide: in vivo bioequivalence R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 611-617, 2004 | 24 | 2004 |
| In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets H Wong, Y Ozalp, A Lainesse, RS Alpan Arzneimittelforschung 54 (09), 618-624, 2004 | 22 | 2004 |
| Effects of vasoactive intestinal polypeptide on isolated rat urinary bladder smooth muscle K Erol, G Ulak, T Dönmez, MII Cingi, RSS Alpan, M Özdemir Urologia internationalis 49 (3), 151-153, 1992 | 22 | 1992 |
| Effect of the combination of lisinopril and hydrochlorothiazide on the bioequivalence of tablet formulations R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 605-610, 2004 | 16 | 2004 |
| Bioequivalence studies on bisphosphonates: the example of alendronate A Lainesse, Y Ozalp, H Wong, RS Alpan Arzneimittelforschung 54 (09), 569-572, 2004 | 14 | 2004 |
| Serotonin reuptake inhibitors: bioequivalence of sertraline capsules R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 629-633, 2004 | 12 | 2004 |
| Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display method RS Alpan, S Sparvero, AB Pardee Molecular Medicine 2, 469-478, 1996 | 11 | 1996 |
| Studies on the bioequivalence of second generation cephalosporins: cefaclor capsules and suspension R Koytchev, Y Ozalp, A Erenmemisoglu, N Tyutyulkova, E Gatchev, ... Arzneimittelforschung 54 (09), 583-587, 2004 | 10 | 2004 |
| Studies on the bioequivalence of different strengths of tablets containing clarithromycin R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 588-593, 2004 | 7 | 2004 |
| Assessment of the bioequivalence of different formulations containing azithromycin (tablets and suspension) R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 578-582, 2004 | 7 | 2004 |
| Clinical relevance of bioequivalence acceptance criteria R Koytchev, A Erenmemisoglu, MJ van der Meer, S Alpan Arzneimittelforschung 53 (04), 289-293, 2003 | 7 | 2003 |
| Bioequivalence study of rofecoxib tablets R Koytchev, Y Ozalp, A Erenmemisoglu, MJ van der Meer, RS Alpan Arzneimittelforschung 54 (09), 624-628, 2004 | 5 | 2004 |
| Effect of the Formulation on the Bioequivalence of Sultamicillin: Tablets and Suspension R Koytchev, Y Ozalp, A Erenmemisoglu, U Kunter, RS Alpan Arzneimittelforschung 54 (09), 634-639, 2004 | 3 | 2004 |
| The effect of polymorphisms in CYP2C9, CYP4F2, EPHX1 and VKORC1 on warfarin dose in Turkish patients M Ozer, Y Demirci, S Sarikaya, I Karalti, C Kaspar, C Hizel, S Alpan, ... Current Opinion in Biotechnology, S125, 2011 | 2 | 2011 |
Yildiz OzalpAssoc.Prof / Near East Universityneu.edu.tr üzerinde doğrulanmış e-posta adresine sahip
